Results 311 to 320 of about 829,320 (360)

Adjuvant Radiotherapy for Keloids

Aesthetic Plastic Surgery, 2021
Radiotherapy is one of the therapeutic methods for keloids, and the irradiation technique has innovated from superficial X-ray to brachytherapy after decades of clinical practice. At present, the application of adjuvant radiotherapy has been widely accepted by clinicians, while the consensus of optimal adjuvant radiotherapy strategies for keloids has ...
Bin Qiu, Fei Fan, Wenfang Dong
openaire   +3 more sources

Adjuvant radiotherapy for atypical meningiomas

Journal of Neurosurgery, 2016
OBJECTIVEThe aim of this paper was to evaluate outcomes in patients with atypical meningiomas (AMs) treated with surgery alone compared with surgery and radiotherapy at initial diagnosis, or at the time of first recurrence.METHODSPatients with pathologically confirmed AMs treated at the University of Utah from 1991 to 2014 were retrospectively reviewed.
William T. Couldwell, Dennis C. Shrieve, Hilary P. Bagshaw, Gita Suneja, Cheryl A. Palmer, Lindsay M. Burt, Randy L. Jensen   +6 more
openaire   +4 more sources

Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization

Clinical and Translational Oncology, 2018
It is estimated that more than half of cancer patients undergo radiotherapy during the course of their treatment. Despite its beneficial therapeutic effects on tumor cells, exposure to high doses of ionizing radiation (IR) is associated with several side effects.
Elahe Motevaseli, Ensieh Salehi, Ahmed Eleojo Musa, Nasser Hashemi Goradel, Keywan Mortezaee, Maryam Shabani Nashtaei, Neda Khanlarkhani, Bagher Farhood, Hanifeh Mirtavoos-Mahyari, Masoud Najafi, Dheyauldeen Shabeeb, Dheyauldeen Shabeeb   +11 more
openaire   +4 more sources

Camouflaged Nanoreactors Mediated Radiotherapy-Adjuvant Chemodynamic Synergistic Therapy.

ACS Nano, 2023
Chemodynamic therapy based on the Fenton-like catalysis ability of Fe3O4 has the advantages of no involvement of chemical drugs and minimal adverse effects as well as the limitation of depletable efficacy.
Mingze Lu, Haoan Wu, Di Liu, Fei Wang, Yan Wang, Mengjun Wang, Qiannan Cui, He Zhang, Fengchao Zang, Ming Ma, Jun Ma, Fangfang Shi, Yu Zhang   +12 more
semanticscholar   +1 more source

ATP‐Responsive Smart Hydrogel Releasing Immune Adjuvant Synchronized with Repeated Chemotherapy or Radiotherapy to Boost Antitumor Immunity

Advances in Materials, 2021
Certain chemotherapeutics and forms of ionizing radiation can induce immunogenic cell death (ICD). If there simultaneously exist immune adjuvants within the tumor, such antitumor immunity would be further amplified.
Lele Sun, Fengyun Shen, Longlong Tian, Huiquan Tao, Zijian Xiong, Jun Xu, Zhuang Liu   +6 more
semanticscholar   +1 more source

Efficacy and prognostic factors of adjuvant radiotherapy for cutaneous squamous cell carcinoma: A systematic review and meta‐analysis

Journal of the European Academy of Dermatology and Venereology, 2021
Although adjuvant radiotherapy has been used for cutaneous squamous cell carcinoma, its outcome benefits, especially for patients with clear surgical margins, have not been statistically estimated, and the characteristics that can indicate patients who ...
Jinjue Zhang, Yixi Wang, Wilson A. Wijaya, Zhong-xiao Liang, Junjie Chen   +4 more
semanticscholar   +1 more source

Adjuvant radiotherapy in urothelial neuroendocrine carcinoma

Minerva Chirurgica, 2020
Neuroendocrine carcinoma cases, more frequent in the gastro-intestinal and pulmonary tract, have rarely been reported also in other areas, including the genito-urinary system. The majority of genitourinary neuroendocrine carcinomas occur in the bladder, being upper urinary tract neuroendocrine carcinoma rare.
Rossi R. E., Monteleone M., Altomare M., Cattaneo L., Torchio M., Coppa J., Mazzaferro V.   +6 more
openaire   +3 more sources

The Impact of Adjuvant Radiotherapy on Carcinosarcoma of the Uterus [PDF]

Gynecologic Oncology, 1998
The role of adjuvant radiotherapy in the setting of uterine carcinosarcoma has not been clearly established.A retrospective review of 60 patients receiving definitive therapy for carcinosarcoma of the uterus was undertaken at a single institution.
Joseph L. Kelley, Quingshou Huang, Clare M. Faul, Sophia Kounelis, Kristina Gerszten, Mirka W. Jones   +5 more
openaire   +2 more sources

Adjuvant radiotherapy for breast cancer

BMJ, 2008
Changes in delivery must be driven by evidence from ongoing clinical trials The incidence of breast cancer is rising worldwide, particularly in women over 50—it increased by 30-40% between 1973 and 1997.1 In the United States it has decreased by around 10% in line with the reduced use of hormone replacement therapy, but globally the problem is growing.
Hiley, Crispin, Tutt, Andrew, Torres, Mylin, Palmieri, Carlo   +3 more
openaire   +3 more sources